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Validation of a revised slow-stop flow recirculation method
Technical Note
ToRos KAPOIAN, CAROLINE A. STEWARD, and RICHARD A. SHERMAN
Department of Medicine, Division of Nephrology, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
Validation of a revised slow-stop flow recirculation method. Technical
Note. Slow flow/stop flow methods have replaced the three needle tech-
nique as methods of choice for measuring recirculation. However, the time
delay after reducing blood flow may affect the BUN in the systemic (slow
flow/stop flow arterial line) sample and therefore limit the accuracy of this
methodology. It has been observed that recirculatiun does not occur in a
properly cannulated access unless the access blood flow rate is less than
the dialyzer blood flow rate (BFR). This suggests that the systemic sample
could be obtained at a higher than usual blood pump rate. We studied 50
patients and compared a revised slow-stop flow (S/SF) recirculation
technique in which the systemic sample was drawn after the blood pump
rate was reduced to 120 mI/mm for 10 seconds and then stopped, to a
non-urea based method that utilized indicator velocity dilution (IVDM).
Seven patients were found to have recirculation by IVDM; all had
recirculation by S/SF of more than 10% (minimum 16.7%) and an access
BFR that was less than the dialyzer BFR. In the 43 patients without
recirculation by IVDM, the mean recirculation by S/SF was 1.9 3.2%
(mean SD). Five patients without recirculation by IVDM had more than
5% recirculation by S/SF (range, 5.9 to 8.3%). Although there was a small
systematic tendency to Overestimate recirculation, this modified urea
based method was still able to detect recirculation with good reliability.
Single values above 10% are highly likely to indicate the presence of true
recirculation. Repeated values over 5% are also likely to be significant,
indicating the presence of true recirculation and its clinical correlate,
marginal access blood flow.
Slow flow/stop flow methods of measuring recirculation (R) are
easier, less traumatic and more accurate than the three needle
method which requires a peripheral venous puncture. With these
"two needle" recirculation methods, the "systemic" sample is
obtained from the arterial blood line a short time (about 30
seconds) after slowing (to about 50 mI/mm) or stopping blood
flow. The delay after reducing blood flow is necessary to clear the
"dead space" between the dialysis needle and the sampling port,
which may contain recirculated blood. The length of this delay is
problematic. Too long a delay after slowing or stopping dialysis
will allow the BUN to rebound in the systemic sample (due to
reversal of cardiopulmonary recirculation), giving a falsely high
calculated recirculation value. On the other hand, too a short a
delay risks obtaining a sample contaminated with recirculated
blood, falsely lowering calculated recirculation.
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The minimum required time delay before the systemic sample
can be obtained from the arterial line depends upon the dead
space volume to be cleared and the blood pump rate during the
slow flow period. This rate has traditionally been very low (50
mi/mm) to avoid inducing recirculation, Recent data indicate that
urea rebound in arterial blood begins within 10 to 15 seconds after
dialysis stops [11, a time period that is insufficient to assure
clearing of the dead space when a blood pump rate of 50 mI/mm
is used.
The resolution of this conundrum became apparent with the
observation that recirculation does not occur in a properly
cannulated arteriovenous access unless the access blood flow rate
(BFR) is less than the dialyzer BFR [2—4]. Thus, concern about
inducing recirculation that is otherwise absent by using a pump
speed of more than 50 mi/mm is usually unwarranted. It follows
that a systemic sample can be obtained using a higher than
customary blood pump rate with no risk of inducing recirculation
unless the access BFR is strikingly low (in which case the
calculated recirculation will still be very high and the error in
measurement will be clinically insignificant). This higher pump
speed will allow a reduction in the time delay needed for clearing
the dead space and eliminate the problem of urea rebound.
Theoretically this should obviate prior difficulties with the slow
flow/stop flow recirculation method.
We therefore studied a revised slow-stop flow (S/SF) technique
in which the systemic sample was drawn after the blood pump rate
was reduced to 120 mI/mm for 10 seconds and then stopped. This
method was compared to a non-urea based method that has
previously been shown to accurately assess recirculation [1, 5, 6].
METHODS
Patients
Fifty adult patients were selected to participate in this study,
which was approved by our Institutional Review Board. We
attempted to include patients with suspected access dysfunction in
order to evaluate this method in the presence of recirculation.
Informed consent was obtained from all patients. All patients
were receiving chronic hemodialysis thrice weekly for three to
four hours at a pump speed of 380 to 500 mi/mm (mean 492
ml/min) using high-flux polysulfone dialyzers (F80, Fresenius
USA, Walnut Creek, CA, USA). Thirty-eight patients had poly-
tetraflouroethylene grafts (AVG): 22 forearm (21 loop, 1 straight)
and 16 upper arm (12 loop, 4 straight). Twelve patients had
autogenous fistulae (AVF; 11 forearm, 1 upper arm). Patients
were studied once during the first half of dialysis (mean time 59
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Table 1. Revised slow-stop flow urea recirculation method
1. Set pump speed to desired rate for at least 3 minutes.
2. Obtain venous (V) and arterial (A) samples.
3. Reduce pump speed to 120 mI/mm for exactly 10 seconds then stop
pump.
4. Clamp above arterial sampling port.
5. Obtain systemic (S) sample from arterial sampling port.
6. Calculate recirculation (R):
[S — A]R = [S — V]>< 100%
Table 2. Mean values (±SD) for flow rates and recirculation
R[tVDM]
(N)
R[IVDM] R[S/SFI
%
Access BFR D
mI/mm
iyzer BFR
Present
(7) 33.3 14.3 26.9 10.4 254 70 502 59
Absent
(43) 0 0 1.9 3.2 870 307 513 33
P value — — <0.0001 NS
NS is not significant. Other abbreviations are in the text.
Measured by ultrasonic transit time
mm, range 5 to 180 mm into treatment) and served as their own
control.
Methods
The blood pump rate was set to 500 ml/min or to the maximum
rate achievable within the set arterial and venous pressure limits.
The ultrafiltration rate was set to the lowest level (0.1 mI/mm).
Recirculation (R) was first measured using an indicator velocity
dilution method (IVDM) (Transonic Hemodialysis Monitor,
Transonic Systems, Inc., Ithaca, NY, USA) as previously de-
scribed [1]. All IVDM measurements were performed in triplicate
and the mean values were recorded for the purposes of this study.
Recirculation was then measured using urea based methodology
(S/SF) (Table 1). The systemic sample was drawn after the blood
pump rate was reduced to 120 ml/min for exactly 10 seconds
(allowing 20 ml of blood to be cleared). A slow-flow rate of 120
mi/mm was chosen in order to clear 150% of the largest dead
space (13 ml) in commercially available blood lines in use in the
United States (J.T. Daugirdas, personal communication).
The blood lines were then reversed in a sterile manner and the
blood pump rate was set to 300 ml/min. Access blood flow rate
(BFR) was determined by IVDM as previously described [7, 8].
All blood samples for BUN assessment were processed at the
same laboratory (DCI Laboratories, Nashville, TN, USA) using
the same auto-analyzer (American Monitor Excell; Integrated
Clinical Systems USA, Indianapolis, IN, USA) and the same
chemical reagents (Synermed, Montreal, Canada). Since the rate
of blood flow in the dialyzer is not necessarily equal to the blood
pump rate set on the dialysis machine, we directly measured the
dialyzer BFR using a flow probe (Transonic Hemodialysis Mon-
itor; Transonic Systems, Inc., Ithaca, NY, USA).
Recirculation was calculated in the standard fashion:
where A and V represent the urea concentration in the arterial
and venous line blood samples and S represents the urea concen-
tration in the arterial line blood sample after reducing dialyzer
BFR to 120 mI/mm for 10 seconds. Statistical analysis was
performed using Statgraphics (SYSC-Plus-Ware, Rockville, MD,
USA).
RESULTS
Mean values for flow rates (S/SF is slow-stop flow) and recir-
culation (R) are given for all patients in Table 2. Seven of 50
patients were found to have recirculation by the indicator velocity
dilution method (IVDM). Individual values for all patients with
R[S/SF] > 5% are shown in Table 3.
All patients with R[IVDM] had R[S/SF] greater than 10%,
yielding a sensitivity and specificity of 100% for this threshold
value (Table 4). Although an R[S/SF] threshold of 5% identified
all patients with recirculation by IVDM, it misclassified (false
positive) five patients. All patients with recirculation by IVDM
had an access BFR that was less than the dialyzer BFR (mean
difference, 248.6 ml/min, range 170 to 336 ml/min). All "false
positive" patients, that is, R[IVDM] = 0, R[S/SF] > 5%, had an
access BFR greater than the dialyzer BFR (mean access BFR, 817
mi/mm, range 413-1603). This access BFR did not differ from the
mean access BFR of 877 mI/mm in the "true negative" (R[IVDMI
= 0, R[S/SF] < 5%) patients.
DISCUSSION
The measurement and interpretation of recirculation during
hemodialysis, a seemingly simple concept, has become a confusing
subject in recent years. As a result of our better understanding of
intradialytic urea kinetics, the development of non-urea based
means of measuring recirculation and the ability to accurately
assess access blood flow rate, the pathophysiology of recirculation
is now becoming clear.
First, recirculation is relatively rare when measured using
accurate non-urea based methods [1, 3, 5, 9, 101. Our finding of
recirculation in 7 of 50 patients (14%) is an overestimate of the
population frequency since we specifically sought to include
patients with access dysfunction. Consequently, the high fre-
quency of recirculation that has been previously reported using
urea based methods [11—14] overwhelmingly represents false
positive findings. These findings are due to non-recirculation
based differences in arterial line and systemic blood urea concen-
tration resulting from intradialytic urea kinetic effects [2, 4, 15—201
and from small errors in urea measurements [21].
Second, if recirculation is present in a properly cannulated
vascular access, the access blood flow rate (BFR) must be less
than the dialyzer BFR [22]. In our study all 7 patients with
recirculation had an access BFR less than the dialyzer BFR. The
converse, usually, but not always, holds; that is, if the access BFR
is less than the dialyzer BFR, recirculation is usually present. One
exception is the presence of a stenosis between the needles [23].
Thus, the discovery of recirculation indicates that either access
BFR is very low or the access is cannulated incorrectly with the
arterial and venous needles reversed.
Third, it appears that polytetrafluoroethylene grafts (AVGs)
and autogeneous fistulae (AVF5) differ in the likelihood that
recirculation will be present. Compared with AVGs, AVFs more
Table 4. Results of S/SF versus IVDM recirculation methods
Recirculation [IVDM]
Absent Present
38 0
Recirculation [S/SF} >5—10% 5 0
>10% 0 7
often remain patent when their BFRs are very low, increasing the
likelihood that recirculation will be detected. We found recircu-
lation in 3 of 12 AVFs but only 4 of 38 AVGs. This observation is
consistent with other published data [4, 91.
The reasons for the difficulty in developing an accurate two-
needle method for measuring recirculation has been noted earlier.
Our new knowledge has allowed for the development of a simple
solution: obtaining the slow flow systemic sample at a rate that is
not as slow as previously utilized. We now recognize that this
change will cause little inaccuracy, at least not of any clinical
significance. To make this point, consider a simplified case, a
patient with an access BFR of 200 ml/min. receiving treatment
using a dialyzer BFR of 400 mI/mm. Recirculation will be 50% in
this patient since only half the blood flow demanded by the blood
pump can be met by blood entering the access. The other half of
the blood entering the dialyzer must flow retrograde from the
venous needle. If the systemic sample is obtained from the arterial
line at a blood flow rate of 120 ml/min (or even 200 mI/mm), the
underlying access blood flow is sufficient to supply the blood pump
and the systemic sample will not he contaminated by recirculated
blood. As a result, the measured recirculation will be accurate
(50%). What if the access BFR in this situation was only 100
mi/mm? Then recirculation would be 75% but the slow flow
systemic sample obtained at 120 ml/min would contain a small
amount of recirculated blood (20 mi/mm of the 120 mi/mm). As a
result, the BUN in the slow flow systemic sample would be slightly
lower (and the recirculation also slightly lower) than the true
systemic value (and true recirculation). However, the level of
recirculation is so high in this setting that the error produced is
clinically inconsequential. It should also be apparent that a BFR
of 150 mI/mm (rather than 120 mI/mm) would also provide an
accurate systemic sample in cases where machine limitations on
BFR variability exist.
We chose to put this logic to the test and found results that were
as expected. We anticipated that slight errors in the measurement
of BUN would result in false positive elevations in recirculation
with the urea based methodology (S/SF) in some patients without
actual reeirculation; in five eases these values exceeded 5%
(range, 5.9 to 8.3%). However, we were surprised to find a
systematic overestimation of recirculation with the revised
method. In the 43 patients without recirculation by IVDM, we
found a mean value for recirculation by S/SF of 1.9% [95%
confidence interval (CI), 0.9 to 2.9%1 that was statistically differ-
ent from the expected value of zero. Further analysis using the
Wileoxon signed rank test also indicated this value was signifi-
cantly greater than zero; 20 individual S/SF results were greater
than 0%, 3 were less than 0% and the remaining 20 patients
without recirculation by IVDM had R[S/SFI values of 0%.
The basis for this systematic, though very small, tendency to
overestimate reeirculation using this modified method is uncer-
tain. It may reflect unrecognized errors in timing, sampling
technique, or urea rebound occurring even earlier than currently
believed.
Despite this, we found that recireulation can still he detected
with good reliability using a modified urea based method. Intrinsic
variability in urea determination as well as the small systematic
"rebound" error will be responsible for some inaccuracy in the
measurement. In our hands, the highest false positive value was
8.3% among 43 patients without recirculation by IVDM. Single
values above 10% are highly likely to indicate the presence of true
reeireulation. Though not tested, we believe that repeated values
over 5% are also likely to be significant, indicating true recircu-
lation and its clinical correlate, marginal access blood flow.
Reprint requests to Toros Kapoion, M.D., Department of Medicine (Ne-
phrolo), One Robert Wood Johnson Place, CN-J New Brunswick, New
Jersey 08903, USA.
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